Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Ready To Duke It Out With P&G On Rx-To-OTC Switches

This article was originally published in The Tan Sheet

Executive Summary

Bayer looks to challenge Procter & Gamble's goal of becoming the leading Rx-to-OTC switch company
Advertisement

Related Content

One-A-Day for cholesterol
One-A-Day for cholesterol
One-A-Day for cholesterol
Bayer/Roche Consumer Unit Will Focus On Rx-To-OTC Switch Opportunities
Bayer/Roche Consumer Unit Will Focus On Rx-To-OTC Switch Opportunities
Roche Could Have Buyer For OTC Unit By Early Summer
Prilosec OTC Success Has P&G Eyeing Pharma Partner For Next Switch Drug
Prilosec OTC Success Has P&G Eyeing Pharma Partner For Next Switch Drug
Non-Fatal MI Prevention Indication For Aspirin May Cause Bayer Less Pain
Bayer Shuffle To Result In Increased Consumer Care Focus

Topics

Advertisement
UsernamePublicRestriction

Register

PS096600

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel